Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management
This study is currently recruiting participants.
Verified by National Institute on Drug Abuse (NIDA), November 2008
Sponsored by: National Institute on Drug Abuse (NIDA)
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00350649
  Purpose

Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated with enhanced treatment outcomes in CBT. Contingency management (CM) also has very strong support and is associated with rapid, robust effects on targeted outcomes. Despite their many strengths, neither CBT nor CM is universally effective. It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects.


Condition Intervention Phase
Marijuana Dependence
Behavioral: Standard CBT
Behavioral: CBT+CM/adherence
Behavioral: CM/abstinence
Behavioral: CM/abstinence+CBT
Phase II

MedlinePlus related topics: Marijuana
Drug Information available for: Ethanol
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Self reported marijuana use (days of abstinence by week) and results of urine toxicology screens [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Economic analysis with use of PACC-SAT [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 160
Study Start Date: December 2004
Estimated Study Completion Date: September 2010
Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
manualized delivery of CBT by trained clinicians
Behavioral: Standard CBT
Manualized delivery of CBT by trained clinicians
2: Active Comparator
CBT with Contingency Management reinforcement for attendance and completing homework (CBT+CM/adherence)
Behavioral: CBT+CM/adherence
CBT and Clinical Management for attendance and completing homework
3: Experimental
Contingency Management for abstinence alone (CM/abstinence)
Behavioral: CM/abstinence
Contingency Management
4: Active Comparator
Contingency Management integrated with CBT (CM/abstinence+CBT)
Behavioral: CM/abstinence+CBT
Contingency Management for abstinence in addition to manualized CBT delivered by a trained clinician

Detailed Description:

The investigators propose to evaluate targeted strategies to maximize the effectiveness of CBT and CM, respectively. To maximize the effectiveness of CBT, the investigators will evaluate the benefit of adding CM, with reinforcement for session attendance and homework completion, to standard individual CBT for outpatient marijuana abusers, in order to expose participants to more skill training and opportunities for practice of skills. To maximize the effectiveness and durability of CM, we will evaluate the benefit of integrating it with skills training, specifically designed to reduce drop off effects, in order to extend CM's benefits beyond the active treatment period. We propose to conduct a Stage II trial which will: (1) Evaluate the efficacy of four conditions for 160 marijuana dependent outpatients: (a) Standard CBT, (b) CBT with CM reinforcement for attendance and completing homework (CBT+CM/adherence), (c) CM for abstinence alone (CM/abstinence), (d) CM for abstinence integrated with CBT (CM/abstinence+CBT), and (2) Evaluate the longer-term durability and / or delayed emergence of treatment effects after termination of the study treatments through a one-year follow-up. Secondary aims will be to conduct (a) detailed process studies to evaluate whether the proposed enhancements affect proximal and distal outcomes as hypothesized and (b) economic analyses. Study treatments will last 12 weeks.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18-65 year old marijuana dependent
  • willing to sign consent
  • no use of prescribed psychotropic drugs
  • willing to give three individuals as contacts
  • willing to accept randomization
  • read and write English (third grade level)

Exclusion Criteria:

  • unable to commit to 1 year follow up
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00350649

Contacts
Contact: JoAnna DePiono, BA 203-974-5731 joanna.depino@yale.edu
Contact: Rhonda Pruzinski, BA 203-974-5740 rhonda.pruzinski@yale.edu

Locations
United States, Connecticut
ASAP/1 Long Wharf Recruiting
New Haven, Connecticut, United States, 06512
Sponsors and Collaborators
Investigators
Principal Investigator: Kathleen Carroll, PhD Yale School of Medicine
  More Information

Responsible Party: Yale University ( Kathleen Carroll, PhD )
Study ID Numbers: 0407026913
Study First Received: July 7, 2006
Last Updated: November 24, 2008
ClinicalTrials.gov Identifier: NCT00350649  
Health Authority: United States: Federal Government

Keywords provided by National Institute on Drug Abuse (NIDA):
behavior modification
cognitive behavioral therapy
combination therapy
drug abuse therapy
drug addition
human therapy evaluation
psychotherapy
clinical trial phase II
coping
drug and alcohol abstinence
longitudinal human study
outcomes research
outpatient care
psychological reinforcement
therapy compliance
behavior and social research tag
human subjects
neuropsychological test
patient oriented research

Study placed in the following topic categories:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Marijuana Abuse
Ethanol

ClinicalTrials.gov processed this record on January 14, 2009